…According to a recent presentation by European Ecology MEP (Member of the European Parliament) Michèle Rivasi, vaccine safety, “as a general rule, is being questioned” [in France].3 Rivasi went on to say:
Between 2005 and 2010, the proportion of French people in favour or very in favour of vaccination dropped from 90% to 60% (2013 INPES Peretti-Watel health barometer). The percentage of French people between the ages of 18 and 75 who are anti-vaccination increased from 8.5% in 2005 to 38.2% in 2010. In 2005, 58% of doctors questioned the usefulness of vaccines administered to children while 31% of doctors were expressing doubts about vaccine safety. These figures must surely have increased since then.3
The issue of vaccine safety in France received renewed media coverage in April following a report by the country’s Technical Committee of Pharmacovigilance to the Directorate General of Health regarding the deaths of two newborn babies from intussusception in 2012 and 2014 after receiving the Rotarix and RotaTeq vaccines.4 Intussusception is a “serious disorder in which part of the intestine slides into an adjacent part of the intestine.”5 The oral vaccines, produced by GlaxoSmithKline (GSK) and Merck respectively, have also been reported to have caused 500 adverse events—200 of which have been designated as “serious.”4 …
One girl’s ovaries were destroyed, with Gardasil the only potential cause. Worse, though, is that Merck either didn’t bother to examine potential effects on ovaries or hid them—but did examine effects on testes.
The BMJ has published the case report of a healthy 16-year-old Australian girl whose womanhood appears to have been stolen by Gardasil vaccinations. She has been thrust into full-fledged menopause, her ovaries irrevocably shut down, before becoming a woman. The authors, Deirdre Therese Little and Harvey Rodrick Grenville Ward1, draw direct attention to the fact that, though the girl has been thoroughly examined and tested, there is no known explanation other than the series of three Gardasil vaccinations she had…
PROVIDENCE — Starting this fall, seventh-graders in all public and private schools will be required to get a vaccine that protects against a sexually transmitted virus linked to various genital cancers, especially cervical cancer in women.
Students who fail to get the vaccine for HPV — or the human papillomavirus — will be precluded from attending school unless their parents seek an exemption for medical or religious reasons. HPV is the most common sexually transmitted virus in the United States. It is widespread: there are more than 14 million new infections annually, according to the Kaiser Family Foundation.
Rhode Island becomes the third jurisdiction, including Virginia and Washington, D.C., to make the vaccine mandatory.
Locally, some parents are already agitating against the vaccine, saying it’s an intrusion by the government into private matters and that the vaccine’s side effects can be serious.
Elissa Maple was a bright young energetic 16 year old who reached a difficult emotional time in her life, as sixteen is a difficult age for most children. Added to this natural occurrence was her brother’s auto accident which almost took his life, her mother sought help for Elissas’s anxiety. A mother’s care for her child knows no boundaries, but it turned into a nightmare that would have Elissa drugged by hospital officials, kidnapped by DCF, and admitted to a mental facility masquerading as a school in Massachusetts.
It would take almost two years for Elissa to be returned to her home. But the good news is that Elissa Maple is home now and very happy to be there. She’s becoming more relaxed due to spending time with her family and loved ones, activities that make us all feel comfortable about our lives and our futures. However, Elissa and her mother Karen cannot rest easy just yet…
…the introduction of chemotherapy/radiation may cause tumor regression, but the small population that survives (including cancer stem cells) technically comes back even stronger thereafter. In the same way that antibiotics like methicillin spawned the monster that is methicillin-resistant Staphyloccocus aeureus, which creates a population of bacteria with highly up-regulated multidrug resistance proteins and genes, chemotherapy and radiation CREATE a genetically more resistant population of super-cancers, and often is the reason why the patient dies. Sadly, in these cases the death is blamed on the “chemoresistant” and “radioresistant” cancer and the victim is blamed, if you will, for being killed by the very treatment they were being told they would die much sooner without.
Cancer Is “A Symptom” And Not A “Disease.”
So, instead of a monolithic “disease,” it makes more sense to view cancer as a symptom of cellular and environmental conditions gone awry; in other words, the environment of the cell has become inhospitable to normal cell function, and in order to survive, the cell undergoes profound genetic changes, drawing ancient genetic pathways which we associate with the cancerous personality ( phenotype). This “ecological” view puts the center of focus back on the preventable and treatable causes of the “disease,” rather on some vague and out-dated concept of “defective genes” beyond our ability influence directly.
It also explains how the “disease” process may conceal an inherent logic, if not also healing impulse, insofar as it is an attempt of the body to find balance and survive in inherently unbalanced and dangerous conditions. Fundamentally…
As a result of my inquiry for the article “What you didn’t know about a doctor’s stance on the HPV vaccine,” the medical journal Lancet has now issued a correction to its publication.The correction acknowledges formerly undisclosed financial conflicts of interest between the article’s lead author and makers of the controversial human papillomavirus (HPV) cervical cancer vaccine.The article by Dr. Sharon J. B. Hanley defended the vaccine and criticized the Japanese government’s decision to stop promoting the vaccine amid concerns about injuries. It also implied patients are incorrectly blaming the HPV vaccine for unrelated ills.Hanley did not disclose…Continue to the Article Here
Sunday, July 12th Svenska Dagbladet (a Swedish newspaper) released a story giving hope to hundreds of Danish families whose lives turned upside-down when their daughters began to experience multiple new medical conditions after HPV vaccine injections. This newspaper announced the European Medicines Agency (EMA) was launching a probe into possible side effects of the highly controversial HPV vaccines. Finally, these families believed they might get some answers as to why their daughters had transformed from healthy athletic girls to mere shadows of their former selves.
The Svenska Dagbladet article went on to state:
For years, talk of possible risks and side effects from HPV vaccines was rejected by authorities, doctors and drug companies. The decision by EMA in London, which is to be presented on Monday, according to SvD’s sources, is therefore likely to create harsh reactions.
Within a few short hours, the story was confirmed by multiple other news outlets.
A Medscape article stated the EMA had started a review on human papilloma virus (HPV) vaccines to ”further clarify aspects of their safety profile,” although the agency also points out that this review ’does not question that the benefits of HPV vaccines outweigh their risks.” This report also noted that the EMA would make no recommended changes in the use of HPV vaccines while the review was being conducted.
The European Medicines Agency says it has started a review of cervical cancer vaccines to see if they are linked to two rare conditions, but emphasized it hasn’t changed its recommendations for how the shots should be used.
At the request of Denmark, which has seen an increasing number of young girls suffer side effects, the European Medicines Agency said on Monday that it will take a closer look at the HPV vaccine.
The review is being carried out by EMA’s own side effects committee, PRAC, which according to Swedish newspaper Svenska Dagbladet has had internal disagreements over how to handle mounting suspected evidence of medical risks connected to the vaccines.
The safety of the HPV vaccine has today been thrown into doubt as health experts launch a review of the jab amid concerns over its side-effects.
The European Medicines Agency’s probe will focus on rare reports of two conditions, complex regional pain syndrome and postural orthostatic tachycardia syndrome
The EMA was quick to note the review does not question that the benefits of HPV vaccines outweigh the risks.
Suddenly, parents around the world began to experience the same kind of hope those in Denmark did. Someone was finally going to listen to what they had been saying for months, sometimes years. Instead of brushing off their daughters’ (and sons’) new symptoms as psychosomatic, their children’s new medical conditions would be examined as possible side effects of the HPV vaccines they all had taken.
This 3 minute Danish news report (with English subtitles) gives an indication of how much families around the world are depending on the outcome of a serious scientific investigation.
Do these parents finally have a reason to be hopeful; or is the light they see at the end of the tunnel an oncoming train?”
What kind of ‘probe’ is the EMA going to conduct?
The documentation provided by the European Medicines Agency regarding this investigation raises many questions about the voracity of their efforts. Let’s start by taking a critical look at the press release distributed by the EMA on July 13th regarding this review.
The first two paragraphs of this press release state:
The European Medicines Agency (EMA) has started a review of HPV vaccines to further clarify aspects of their safety profile. These vaccines have been used in around 72 million people worldwide and their use is expected to prevent many cases of cervical cancer (cancer of the neck of the womb) and various other cancers and conditions caused by HPV. Cervical cancer is the 4th most common cause of cancer death in women worldwide, with tens of thousands of deaths in Europe each year despite the existence of screening programmes to identify the cancer early. The review does not question that the benefits of HPV vaccines outweigh their risks.
As for all licensed medicines the safety of these vaccines is monitored by the Agency’s Pharmacovigilance Risk Assessment Committee (PRAC).
The following statements from the EMA press release are not strictly accurate:
Statement: These vaccines have been used in around 72 million people worldwide.
Fact: No one knows how many people have been injected with HPV vaccines because the vast majority of countries do not record administered doses. At any given time, many of the distributed doses they do keep track of may be in storage awaiting administration.
Statement: Their use is expected to prevent many cases of cervical cancer…
Fact: Note they use the words ‘expected to’ NOT ‘proven to’.
Statement: Cervical cancer is the 4th most common cause of cancer death in women worldwide,
Fact: No mention is made of the fact that over 80% of these cancer deaths occur in low to middle income countries, NOT the European Union.
Statement: …with tens of thousands of deaths in Europe each year, despite the existence of screening programmes to identify the cancer early.
Fact: There may be ‘tens of thousands’ in Europe, but for the European Union the cervical cancer mortality rate is 3.7/100,000 – MUCH lower than the rate of serious adverse events being reported worldwide after HPV vaccinations. Denmark for instance currently reports serious adverse events at a rate of 200/100,000 injected.
This is not exactly a good start if one wants to instill public confidence in the outcome of a safety investigation. How can one trust the outcome of an investigation being conducted by an agency that has so little regard for accuracy in their press releases?
The current review will look at available data with a focus on rare reports of two conditions: complex regional pain syndrome (CRPS, a chronic pain condition affecting the limbs) and postural orthostatic tachycardia syndrome (POTS, a condition where the heart rate increases abnormally after sitting or standing up, causing symptoms such as dizziness and fainting, as well as headache, chest pain and weakness). Reports of these conditions in young women who have received an HPV vaccine have been previously considered during routine safety monitoring by the PRAC but a causal link between them and the vaccines was not established.
Both conditions can occur in non-vaccinated individuals and it is considered important to further review if the number of cases reported with HPV vaccine is greater than would be expected.
In its review the PRAC will consider the latest scientific knowledge, including any research that could help clarify the frequency of CRPS and POTS following vaccination or identify any causal link.
This section raises several questions in the mind of even the most casual observer.
How can they say these two conditions are rare before the investigation is completed?
Since the two conditions have been considered previously, have any communications been issued to medical professionals alerting them to watch for these conditions after HPV vaccines?
Why are they only looking at the frequency of CPRS/POTS following vaccination?
How can an ”expected rate” be determined without examining the frequency of CPRS/POTS in unvaccinated people of the same age group as those receiving HPV vaccines?
Since CPRS/POTS are just now being considered as a potential adverse reaction to HPV vaccines, how can evidence of a potential causal link possibly have been established?
Why were POTS and CRPS chosen for this investigation?
If one wanted to get into a truly serious discussion, they would ask why two rare, difficult to diagnose conditions were chosen to be examined instead of looking at all of the serious symptoms recipients of HPV vaccines are reporting. Is it because the symptoms of both are commonly seen in many other disorders making these two conditions difficult to diagnose?
As a matter of fact, the currently used diagnostic criteria for Complex Regional Pain Syndrome (CPRS) was only published in 2007. Even that set of diagnostic criteria is under review for proposed changes. How is the average medical professional supposed to make an accurate diagnosis of this disorder when the experts can’t agree on how to do so?
The same is true of POTS diagnostic criteria. Post orthostatic tachycardia syndrome is not a disease, but simply a cluster of symptoms that are frequently seen together. Since POTS is not a disease, it is fair to say that POTS is caused by something else. However, figuring out what is causing the symptoms of POTS in each patient can be very difficult, and in many cases, patients and their doctors will not be able to determine the precise underlying cause. This makes it pretty convenient for the stakeholders, wouldn’t you say?
Quite frequently people live with these two conditions for years without receiving an accurate diagnosis. Could that be the reason the EMA chose these two disorders to examine?
These facts make it relatively easy to keep the number of reports low, particularly when quoting the rates against distributed doses instead of administered doses.
Where does that leave all of the HPV vaccine recipients who currently exhibit the symptoms of these two disorders but have not obtained a diagnosis yet?
Unreported with no diagnosis and consequently no treatment protocol!
Who does the EMA turn to in order to investigate these potential safety concerns?
Believe it, or not – In order to examine potential safety concerns with Gardasil/Silgard, Gardasil 9 and Cervarix the Pharmacovigilance Risk Assessment Committee (PRAC) is going to question the Marketing Authorization Holders (MAH’s). The Marketing authorisation holders for these products are GlaxoSmithKline Biologicals, Merck Sharp & Dohme Limited, and Sanofi Pasteur MSD.
How insane can one get? These are the very organizations which stand to lose the most should a safety issue be proven regarding HPV vaccines. Does anyone in their right mind think these organizations are going to be transparent when it comes to anything that could substantially effect their bottom line?
The EMA did mention examining data, but will this data come from anyone outside the marketing authorization holders’ control?
Why did the PRAC make no mention of efforts to interview the families of those affected?
Why are they making no apparent effort to talk to physicians on the ground – the people most likely to have experience observing new medical conditions after HPV vaccine administration?
Is the PRAC going to extend their probe to include examination of peer-reviewed publications indicating possible safety concerns surrounding HPV vaccines? Better yet, how about talking to the authors of these publications?
So, what hope do thousands of affected families have?
In this particular instance, there is a great deal of hope. The EMA may have been able to conduct their investigations like this in the past. This time it will not work.
Parents of those with new medical conditions after HPV vaccine administration are not isolated and alone. They have united around the world. They do not want further clarification – they want the truth. They are watching.
Medical and scientific professionals with genuine concerns about the safety, efficacy and need for HPV vaccinations are speaking out. They are willing fight to protect the health of future generations. They are watching.
Business as usual will no longer suffice. Medical consumers around the world will accept nothing less than open, honest scientific investigations regarding HPV vaccine issues.
The families of those negatively affected by HPV vaccine use will not surrender until their children’s health issues have been properly investigated, successful treatment protocols have been designed, and mechanisms put in place to guarantee this type of medical experimentation never gets out of hand again.
Citizens of the world will no longer stand back and allow government health officials to betray the public trust!
